MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 12.11.2025
Adverum Biotechnologies Anteile 2011-2025 | ADVM
Anteile Jährlich Adverum Biotechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.8 M | 10.1 M | 99.3 M | 98 M | 64.1 M | 64.1 M | 61.4 M | 43.7 M | 36.2 M | 25.9 M | 22.8 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 99.3 M | 10.1 M | 49.6 M |
Anteile Vierteljährlich Adverum Biotechnologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.5 M | 21 M | 20.9 M | 20.9 M | 20.9 M | 16.5 M | 10.1 M | 10.1 M | 10 M | - | 99.5 M | 99 M | 98.6 M | 98.4 M | 98.1 M | 98 M | 97.8 M | 97.5 M | 88.9 M | 80.2 M | 73.8 M | 67.3 M | 64.5 M | 63.7 M | 63.1 M | 63 M | 62.5 M | 62.4 M | 57.4 M | 49 M | 43.4 M | 43 M | 42.1 M | 41.8 M | 41.4 M | 35 M | 27.1 M | 25.9 M | 25.7 M | 25.6 M | 24.9 M | 22.8 M | 16.4 M | 3.67 M | 3.67 M | 3.67 M | 3.67 M | 3.67 M | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 99.5 M | 3.67 M | 46.2 M |
Anteile anderer Aktien in der Pharmaeinzelhändler
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M |  USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
54.8 M | $ 220.27 | 4.81 % | $ 5 B |  Danmark |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.18 B | $ 0.28 | -2.28 % | $ 609 M |  Israel |
 |
Alterity Therapeutics Limited
ATHE
|
2.41 B | $ 3.3 | -3.51 % | $ 7.94 B |  Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Aptorum Group Limited
APM
|
5.45 M | $ 1.29 | -3.01 % | $ 7.03 M |  China |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
166 M | $ 4.75 | 1.61 % | $ 788 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
77.3 M | $ 3.26 | -3.12 % | $ 252 M | USA |
 |
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.21 B | - | -15.15 % | $ 60.3 M | Britain |
 |
Aeglea BioTherapeutics
AGLE
|
60.3 M | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
48.4 M | $ 25.27 | -2.43 % | $ 1.22 B | USA |
 |
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |
 |
Anika Therapeutics
ANIK
|
14.7 M | $ 9.57 | 0.84 % | $ 140 M | USA |
 |
BioNTech SE
BNTX
|
244 M | $ 94.73 | -1.32 % | $ 27.2 B | Germany |
 |
Arena Pharmaceuticals
ARNA
|
60.8 M | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
224 M | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | USA |
 |
Avenue Therapeutics
ATXI
|
1.3 M | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
44.3 M | - | 1083.1 % | $ 745 M | USA |
 |
Axon Enterprise
AXON
|
75.7 M | $ 566.18 | -2.56 % | $ 42.9 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
6.28 M | $ 2.34 | 2.59 % | $ 14.7 M | USA |
 |
AstraZeneca PLC
AZN
|
1.42 B | $ 89.78 | -0.57 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
5.39 M | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
219 M | $ 9.09 | -0.55 % | $ 1.5 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
1.37 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
64.7 M | $ 11.54 | 0.87 % | $ 746 M | USA |
 |
Biogen
BIIB
|
146 M | $ 174.42 | 1.11 % | $ 25.4 B | USA |
 |
BioVie
BIVI
|
1.48 M | $ 1.42 | -5.96 % | $ 2.1 M | USA |
 |
Abeona Therapeutics
ABEO
|
21.4 M | $ 5.36 | -2.99 % | $ 115 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
130 M | $ 10.85 | -0.14 % | $ 1.41 B | USA |
 |
ADiTx Therapeutics
ADTX
|
13.2 K | $ 2.3 | -3.0 % | $ 30.3 K | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
30.8 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
68.9 M | - | -7.31 % | $ 87 M | USA |
 |
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Завод ДИОД
DIOD
|
91.5 M | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
301 M | - | - | - | Russia |
 |
BioLineRx Ltd.
BLRX
|
663 M | $ 3.17 | -1.86 % | $ 908 M | Israel |
 |
bluebird bio
BLUE
|
110 M | - | - | $ 546 M | USA |